Teradyne price target lowered to $105 from $140 at Northland

Northland analyst Gus Richard lowered the firm’s price target on Teradyne (TER) to $105 from $140 and keeps an Outperform rating on the shares. Teradyne guided Q2 revenue down 5%-10% quarter-over-quarter and now expects calendar year 2025 revenue growth of 5%-10%, down from 15% previously guided, notes the analyst. While the firm trims its 12-month target on lower calendar 2026 estimates and multiple compression, it argues that “shares look compelling on a longer-term horizon.”